Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation

M. van Gelder, L. C. de Wreede, M. Bornhaeuser, D. Niederwieser, M. Karas, N. S. Anderson, M. Gramatzki, P. Dreger, M. Michallet, E. Petersen, D. Bunjes, M. Potter, D. Beelen, J. J. Cornelissen, I. Yakoub-Agha, N. H. Russell, J. Finke, H. Schoemans, A. Vitek, A. Urbano-IspizuaD. Blaise, L. Volin, P. Chevallier, D. Caballero, H. Putter, A. van Biezen, A. Henseler, S. Schoenland, N. Kroeger, J. Schetelig*, Chronic Malignancy Working Party

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)372-380
Number of pages9
JournalBone Marrow Transplantation
Volume52
Issue number3
DOIs
Publication statusPublished - Mar 2017

Keywords

  • CHRONIC LYMPHOCYTIC-LEUKEMIA
  • HEMATOPOIETIC-CELL TRANSPLANTATION
  • LATE MORTALITY
  • FOLLOW-UP
  • RISK CLL
  • OUTCOMES
  • IBRUTINIB
  • RELAPSE
  • ERA

Cite this

van Gelder, M., de Wreede, L. C., Bornhaeuser, M., Niederwieser, D., Karas, M., Anderson, N. S., Gramatzki, M., Dreger, P., Michallet, M., Petersen, E., Bunjes, D., Potter, M., Beelen, D., Cornelissen, J. J., Yakoub-Agha, I., Russell, N. H., Finke, J., Schoemans, H., Vitek, A., ... Chronic Malignancy Working Party (2017). Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation. Bone Marrow Transplantation, 52(3), 372-380. https://doi.org/10.1038/bmt.2016.282